Development of a high-capacity MAb capture step based on cation-exchange chromatography

BioProcess International

Volumn 7, Issue 5, 2009, Pages 26-34

  Lain, Blanca ^a   Cacciuttolo, Marco A ^a   Zarbis Papastoitsis, Gregory ^a  

^a Percivia LLC   (United States)

Author keywords

Binding capacity; Cation exchange chromatography; Protein A

Indexed keywords

PROTEIN A;

BINDING AFFINITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL PERMEATION CHROMATOGRAPHY; ION EXCHANGE CHROMATOGRAPHY; PROTEIN BINDING; PROTEIN EXPRESSION; SHORT SURVEY;

EID: 77953425069     PISSN: 15426319     EISSN: None     Source Type: Trade Journal    
DOI: None     Document Type: Short Survey

References (21)

1. Kagel RA, Kagel GV, Garg VK. High Performance Protein A and Immuno-Affinity Chromatography for the Commercial Purification of Anti-Human Tissue Plasminogen Activator. BioChromatogr. 4(5)1989: 246-252.
2. Godfrey MAJ, et al. Assessment of the Suitability of Commercially Available SpA Affinity Solid Phases for the Purification of Murine Monoclonal Antibodies at Process Scale. J. Immunol. Meth. 160(1) 1993: 97-105.
3. Fahrner RL, et al. Industrial Purification of Pharmaceutical Antibodies: Development, Operation, and Validation of Chromatography Processes. Biotechnol. Genet. Eng. Rev. 18, 2001: 301-327.
4. Ey PL, Prowse SJ, Jenkin CR. Isolation of Pure IgG1, IgG2a and IgG2b Immunoglobulins from Mouse Serum Using Protein A-Sepharose. Immunochem. 15(7) 1978: 429-436.
5. Surolia A, Pain D, Khan MI. Protein A: Nature's Universal Anti-Antibody. Trends Biochem. Sci. 7(2) 1982: 74-76.
6. Lindmark R, Thorén-Tolling K, Sjöquist J. Binding of Immunoglobulins to Protein A and Immunoglobulin Levels in Mammalian Sera. J. Immunol. Meth. 62(1) 1983: 1-13.
7. Füglistaller P. Comparison of Immunoglobulin Binding Capacities and Ligand Leakage Using Eight Different Protein A Affinity Chromatography Matrices. J. Immunol. Meth. 124(2) 1989: 171-177.
8. Reis KJ, Boyle MD, Ayoub EM. Identification of Distinct Fc-Receptor Molecules on Streptococci and Staphylococci. J. Clin. Lab. Immunol. 13(2) 1984: 75-80.
9. Hale G, et al. Repeated Cleaning of Protein A Affinity Column with Sodium Hydroxide. J. Immunol. Meth. 171(1) 1994: 15-21.
10. Hahn R, et al. Comparison of Protein A Affinity Sorbents III: Life Time Study. J. Chromatogr. A 1102(1-2) 2006: 224-231.
11. Gagnon P. Purification Tools for Monoclonal Antibodies. Validated Biosystems: Tucson, AZ, 1996.
12. Carter-Franklin JN, et al. Fragments of Protein A Eluted During Protein A Affinity Chromatography. J. Immunol. Meth. 160(1) 1993: 97-105.
13. Silverman GJ, Goodyear CS, Siegel DL. On the Mechanism of Staphylococcal Protein A Immunomodulation. Transfusion 45(2) 2005: 274-280.
14. Coco-Martin JM, Harmsen MM. A Review of Therapeutic Protein Expression By Mammalian Cells. BioProcess Int. 6(4) 2008: 28-33.
15. Wan M. Process Mapping: A Necessary Step in Product Lifecycle. BioProcess Int. Conf. Exhib. October 2004, Boston, MA; www.IBCLifeSciences.com/BPI/US.
16. Bain B, Brazil M. Adalimumab. Nature Rev. Drug Discov. 2, 2003: 693-694.
17. Arunakumari A, Wang J, Ferreira G. Improved Downstream Process Design for Human Monoclonal Antibody Production. BioPharm Int. 20(2) 2007: 36-40.
18. Ferreira GM, et al. A Two-Column Process to Purify Antibodies without Protein A. BioPharm Int. 20(5) 2007: 32-43.
19. Wang J, et al. Optimizing the Primary Recovery Step in Nonaffinity Purification Schemes for HuMAbs. BioPharm Int. 21(3) 2008: 6-10.
20. Follman DK, Fahrner RL. Factorial Screening of Antibody Purification Processes Using Three Chromatography Steps without Protein A. J. Chromatogr. A 1024, 2004: 79-85.
21. Jackewitz A. Reducing Elution Volumes with High Capacity and Improved Mass Transfer Ion-Exchange Resins. BioProcess Int. 6(7) 2008: 108-110.